Medicines A-to-Z

Drug name	NICE TAs	Comments
Etoralac
Etranacogene dezaparvovec (Hemgenix®)	Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B [TA989]
Eucerin® intensive lotion (10% urea)
Eurax hydrocortisone® cream		Mild steroid potency. Post-scabies once infection cleared but itch still present
Everolimus (Afinitor®)	TA432 - Everolimus for advanced renal cell carcinoma after previous treatment TA498 - Lenvatinib with everolimus for previously treated advanced renal cell carcinoma TA449 - Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease TA421 - Everolimus with exemestane for treating advanced breast cancer after endocrine therapy	Negative outcome - CDF funded for renal, NET, breast. For hospital use only.
Everolimus (Votubia®)		As recommended by NHSE Refractory seizures associated with tuberous sclerosis
Evicel		Hospital use only
Evolocumab	TA394 - Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia & Homozygous familial hypercholesterola EMIA in line with NHS England SSC 1649	To be used in line with NICE TA
Evra (patches)		Umbrella service only - patients with compliance problems and metabolic problems
Exemestane tablets	TA112 - Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer